药物分析学报

抽象的

How to Use Novel Oral Anticoagulants during the Periprocedural Period of Atrial Fibrillation Ablation

Akinori Sairaku, Yukihiko Yoshida and Yasuki Kihara

Anticoagulation with novel oral anticoagulants (NOACs) for patients undergoing catheter ablation of atrial fibrillation (AF) has rapidly spread all over the world. Nevertheless, there is a lack of information on how to use the NOACs during the periprocedural period. In this review, we introduced the current trend in the way to use the NOACs during the periprocedural period of the AF ablation, and discussed its problems and future challenges.